- Report
- May 2024
- 176 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- October 2024
- 188 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- October 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- May 2024
- 132 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 132 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- February 2025
- 190 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2022
- 200 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- February 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- November 2022
- 119 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- September 2023
- 160 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- August 2023
- 1079 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- February 2019
United States
From €4273EUR$4,495USD£3,590GBP
- Book
- May 2022
- 1040 Pages
- Book
- May 2022
- 3296 Pages
- Book
- May 2022
- 1040 Pages

Gastroesophageal Reflux Disease (GERD) is a chronic digestive disorder that affects the lower esophageal sphincter (LES), the ring of muscle between the esophagus and stomach. GERD occurs when the LES relaxes too often or for too long, allowing stomach acid to flow back up into the esophagus. Symptoms of GERD include heartburn, regurgitation, chest pain, and difficulty swallowing. Treatment options for GERD include lifestyle changes, medications, and surgery.
The Gastroenterology market is a rapidly growing field, with GERD being one of the most common digestive disorders. GERD is a major cause of morbidity and mortality, and its prevalence is increasing due to lifestyle changes and an aging population. GERD is a major focus of research and development in the Gastroenterology market, with many companies developing new treatments and therapies.
Some companies in the Gastroesophageal Reflux Disease market include AstraZeneca, GlaxoSmithKline, Merck, Pfizer, and Takeda. Show Less Read more